ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,311 | +108.5% | 7,316 | +159.8% | 0.00% | – |
| Q2 2023 | $20,769 | -21.3% | 2,816 | 0.0% | 0.00% | – |
| Q1 2023 | $26,378 | -20.1% | 2,816 | -6.6% | 0.00% | – |
| Q4 2022 | $33,000 | +57.1% | 3,016 | +7.1% | 0.00% | – |
| Q3 2022 | $21,000 | +50.0% | 2,816 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | +7.7% | 2,816 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | +8.3% | 2,816 | +55.1% | 0.00% | – |
| Q4 2021 | $12,000 | -57.1% | 1,816 | -43.5% | 0.00% | – |
| Q3 2021 | $28,000 | +40.0% | 3,212 | +23.6% | 0.00% | – |
| Q2 2021 | $20,000 | +17.6% | 2,598 | +16.9% | 0.00% | – |
| Q1 2021 | $17,000 | +88.9% | 2,223 | +78.4% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 1,246 | +41.4% | 0.00% | – |
| Q3 2020 | $9,000 | – | 881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Interchange Capital Partners, LLC | 11,420 | $90,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 47,097 | $373,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $80,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 99,166 | $784,000 | 0.01% |
| EMFO, LLC | 1,666 | $13,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 34,333 | $272,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 51,466 | $407,000 | 0.00% |
| Tarbox Family Office, Inc. | 332 | $3,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,808 | $30,000 | 0.00% |